SQ-LIP-000001 · v1.0 (current) · machine-readable JSON →
Is lipedema a distinct disease, separate from obesity and lymphedema?
Based on currently indexed evidence and expert consensus, lipedema is treated as a distinct clinical entity, characterized by disproportionate, symmetrical, foot-sparing limb fat that resists conventional weight loss. It is not the same as obesity or lymphedema, although all three can coexist. No objective gold-standard diagnostic test exists; the distinction rests on clinical criteria and expert consensus.
Knowledge freshness = share of the 7 indexed evidence sources from the last 5 years (newest 2025, oldest 2019) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
supporting contradicting refining / context Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
What changed in this version
Initial version (v1.0): 5 founding claims indexed from the lipedema pilot. The automated surveillance loop (new-article ingestion → supports / contradicts / refines) has not yet run.
Supporting claims
- SCR-LIP-000001 supporting
Lipedema is a distinct clinical entity separate from obesity and lymphedema, characterized by bilateral, symmetrical, painful subcutaneous fat accumulation of the lower limbs that spares the feet, although all three can coexist.
DOI:10.1590/1677-5449.202301832 · amato_2020_lipedema-unique-entity.pdf - SCR-LIP-000044 supporting
Lipedema is defined by a disproportionate, symmetrical accumulation of subcutaneous adipose tissue in the limbs relative to the trunk that is characteristically resistant to conventional weight-loss methods (diet and exercise), distinguishing it from common obesity.
DOI:10.1590/1677-5449.202301832 - SCR-LIP-000003 supporting
In the Brazilian Delphi consensus, experts agreed that lipedema and obesity do not have a causal relationship and that BMI is of limited value in differentiating lipedema from obesity.
DOI:10.1590/1677-5449.202301832
Contradictory claims
- None indexed yet.
Refining / context
- SCR-LIP-000002 context
Clinical signs that help diagnose lipedema and distinguish it from lymphedema include a usually negative Kaposi-Stemmer sign, the cuff sign with foot sparing, fat painful on palpation, easy bruising, and minimal pitting edema (Stemmer becomes positive only when secondary lymphedema/lipolymphedema develops).
DOI:10.1590/1677-5449.202301832 · Amato_2019_Lipedema_obesidade_linfedema_insuficiencia_venosa.pdf - SCR-LIP-000045 context
Patients with lipedema frequently report swelling and a sensation of heaviness in the affected limbs.
DOI:10.1590/1677-5449.202301832
Major uncertainty
There is no validated biomarker; the boundary with obesity is defined clinically, not biologically.
Version history
- SQ-LIP-000001 · v1.0 — 2026-05-30 — founding index (5 claims) · view this version